Cardiac epigenetics delves into the intricate world of molecular modifications that impact gene expression and function in the heart. Unlike genetic changes, these alterations don't involve modifications to the DNA sequence itself but rather influence how genes are activated or silenced. This field of research is a vital component of cardiovascular science, offering profound insights into the mechanisms governing heart health and disease. Scientists in the realm of cardiac epigenetics explore how various factors, such as lifestyle choices, environmental exposures, and the natural aging process, can induce changes in epigenetic marks. These modifications, in turn, have profound effects on cardiac development, function, and responses to different stressors. As we unravel the complexities of cardiac epigenetics, we unlock the potential for groundbreaking advancements in our understanding of cardiovascular diseases, opening avenues for innovative therapeutic strategies customized to address specific epigenetic signatures linked to heart health.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt